{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T19:10:41Z","timestamp":1790104241716,"version":"4.0.1"},"reference-count":29,"publisher":"FapUNIFESP (SciELO)","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"am","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arq. Gastroenterol."],"abstract":"<jats:p>ABSTRACT  Background: Celiac disease is a chronic autoimmune disorder triggered by gluten ingestion in genetically predisposed individuals, leading to intestinal damage. Probiotics have been studied for their potential benefits in modulating gut microbiota and alleviating gastrointestinal symptoms, which may be beneficial in managing celiac disease (CD).  Objective: In this way, this study evaluated the effects of probiotics compared to placebo in individuals with CD over the course of treatment.  Methods: A total of 85 participants, with an average age of 40 years, were randomized into two groups using a computer-generated list: 39 receiving placebo and 46 receiving a probiotic blend of Bifidobacterium lactis CCT 7858 and Lactobacillus rhamnosus CCT 7863 (1 x 109 CFU\/day) over 90 days. Participants received either a daily probiotic capsule or an identical placebo made from maltodextrin, provided by Gabbia Biotecnologia Ltda. The randomization process and group assignments were concealed from both participants and investigators.  Results: Both groups exhibited similar demographic and clinical characteristics, with most participants symptomatic for CD and adhering to a gluten-free diet. The Bristol Stool Form Scale (BSFS) showed a predominance of normal stool forms in both groups, with a higher prevalence of type 4 in the probiotic group. Gastrointestinal Symptom Rating Scale (GSRS) scores improved significantly in the probiotic group compared to placebo. Additionally, the probiotic group showed significant improvements in emotional well-being and gastrointestinal symptoms, leading to a better quality of life, as measured by the CD-specific quality of life (CD-QOL) scores.  Conclusion: These results suggest that probiotics contribute to symptom improvement and enhanced quality of life in CD patients.<\/jats:p>","DOI":"10.1590\/s0004-2803.24612024-111","type":"journal-article","created":{"date-parts":[[2025,7,21]],"date-time":"2025-07-21T15:04:53Z","timestamp":1753110293000},"source":"Crossref","is-referenced-by-count":2,"title":["PROBIOTICS AS AN ADJUNCTIVE THERAPY FOR CELIAC DISEASE: SYMPTOM RELIEF AND QUALITY OF LIFE IMPROVEMENT"],"prefix":"10.1590","volume":"62","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5867-2884","authenticated-orcid":false,"given":"Gabriel Fernandes Alves","family":"JESUS","sequence":"first","affiliation":[{"name":"Gabbia Biotecnologia,  Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8440-1976","authenticated-orcid":false,"given":"Monique","family":"MICHELS","sequence":"additional","affiliation":[{"name":"Gabbia Biotecnologia,  Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4250-6635","authenticated-orcid":false,"given":"Emily","family":"C\u00d3RNEO","sequence":"additional","affiliation":[{"name":"Gabbia Biotecnologia,  Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0894-3014","authenticated-orcid":false,"given":"Marina P","family":"ROSSETTO","sequence":"additional","affiliation":[{"name":"Gabbia Biotecnologia,  Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8350-8429","authenticated-orcid":false,"given":"Alexandre J","family":"FARACO","sequence":"additional","affiliation":[{"name":"Universidade do Extremo Sul Catarinense,  Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7608-0578","authenticated-orcid":false,"given":"Ana Paula","family":"PESARICO","sequence":"additional","affiliation":[{"name":"Universidade Federal do Pampa,  Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"530","published-online":{"date-parts":[[2025]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/S0140-6736(17)31796-8","article-title":"Coeliac disease","volume":"391","author":"Lebwohl B","year":"2018","journal-title":"Lancet"},{"key":"ref2","doi-asserted-by":"crossref","DOI":"10.1016\/j.cgh.2017.06.037","article-title":"Global Prevalence of Celiac Disease: Systematic Review and Meta-analysis","volume":"16","author":"Singh P","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/MCG.0000000000001267","article-title":"Celiac Disease: Extraintestinal Manifestations and Associated Conditions","volume":"54","author":"Therrien A","year":"2020","journal-title":"J Clin Gastroenterol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/0198-8859(90)90111-2","article-title":"Susceptibility to develop celiac disease is primarily associated with HLA-DQ alleles","volume":"29","author":"Spurkland A","year":"1990","journal-title":"Hum Immunol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"2969","DOI":"10.1016\/j.ajpath.2015.07.018","article-title":"Intestinal microbiota modulates gluten-induced immunopathology in humanized mice","volume":"185","author":"Galipeau HJ","year":"2015","journal-title":"Am J Pathol"},{"key":"ref6","first-page":"265","article-title":"Interactions of the Gut Microbiota and the Innate Immune System","author":"Erny D","year":"2022","journal-title":"Frontiers Media SA"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1002\/jcb.22459","article-title":"Bifidobacteria inhibit the inflammatory response induced by gliadins in intestinal epithelial cells via modifications of toxic peptide generation during digestion","volume":"109","author":"Laparra JM","year":"2010","journal-title":"J Cell Biochem"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1099\/jmm.0.47410-0","article-title":"Imbalance in the composition of the duodenal microbiota of children with coeliac disease","volume":"56","author":"Nadal I","year":"2007","journal-title":"J Med Microbiol"},{"key":"ref9","doi-asserted-by":"crossref","DOI":"10.3390\/life13102039","article-title":"The Role of Intestinal Microbiota in Celiac Disease and Further Therapeutic Perspectives","author":"Belei O","year":"2023","journal-title":"Life"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"202","DOI":"10.4103\/0255-0857.53201","article-title":"Probiotics","volume":"27","author":"Gupta V","year":"2009","journal-title":"Indian J Med Microbiol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.14309\/ajg.0000000000000749","article-title":"Probiotics for Celiac Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials","volume":"115","author":"Seiler CL","year":"2020","journal-title":"Am J Gastroenterol"},{"key":"ref12","first-page":"S1","article-title":"The potentials of probiotics on gluten hydrolysis; a review study","volume":"13","author":"Ramedani N","year":"2020","journal-title":"Gastroenterol Hepatol Bed Bench"},{"key":"ref13","first-page":"125","article-title":"Probiotics, Prebiotics, Postbiotics and Intestinal Barrier Function","author":"Yi H","year":"2022","journal-title":"Frontiers Media SA"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"929346","DOI":"10.3389\/fmicb.2022.929346","article-title":"How do intestinal probiotics restore the intestinal barrier?","volume":"13","author":"Gou HZ","year":"2022","journal-title":"Front Microbiol"},{"key":"ref15","series-title":"GI Microbiota and Regulation of the Immune System","first-page":"170","author":"Huffnagle GB","year":"2008"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"634897","DOI":"10.3389\/fnut.2021.634897","article-title":"Modulation of Gut Microbiota and Immune System by Probiotics, Pre-biotics, and Post-biotics","volume":"8","author":"Liu Y","year":"2021","journal-title":"Front Nutr"},{"key":"ref17","article-title":"Gluten-Free Diet and Other Celiac Disease Therapies: Current Understanding and Emerging Strategies","author":"Mazzola AM","year":"2024","journal-title":"Nutrients"},{"key":"ref18","doi-asserted-by":"crossref","DOI":"10.3390\/nu14102083","article-title":"Influence of Gluten-Free Diet on Gut Microbiota Composition in Patients with Coeliac Disease: A Systematic Review","author":"Kaliciak I","year":"2022","journal-title":"Nutrients"},{"key":"ref19","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2020.08.007","article-title":"Alterations in Intestinal Microbiota of Children With Celiac Disease at the Time of Diagnosis and on a Gluten-free Diet","volume":"159","author":"Zafeiropoulou K","year":"2020","journal-title":"Gastroenterology"},{"key":"ref20","article-title":"The Impact of Low-FODMAPs, Gluten-Free, and Ketogenic Diets on Gut Microbiota Modulation in Pathological Conditions","author":"Reddel S","year":"2019","journal-title":"Nutrients"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1136\/jcp.2008.061366","article-title":"Specific duodenal and faecal bacterial groups associated with paediatric coeliac disease","volume":"62","author":"Collado MC","year":"2009","journal-title":"J Clin Pathol"},{"key":"ref22","first-page":"9478630","article-title":"Probiotic Species in the Modulation of Gut Microbiota: An Overview","volume":"2018","author":"Azad MAK","year":"2018","journal-title":"Biomed Res Int"},{"key":"ref23","article-title":"Probiotics, prebiotics, and postbiotics in health and disease","volume":"4","author":"Ji J","year":"2023","journal-title":"MedComm"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1097\/MIB.0000000000000750","article-title":"Current Understanding of Dysbiosis in Disease in Human and Animal Models","volume":"22","author":"DeGruttola AK","year":"2016","journal-title":"Inflamm Bowel Dis"},{"key":"ref25","article-title":"Reducing Immunoreactivity of Gluten Peptides by Probiotic Lactic Acid Bacteria for Dietary Management of Gluten-Related Diseases","author":"Leszczy\u0144ska J","year":"2024","journal-title":"Nutrients"},{"key":"ref26","doi-asserted-by":"crossref","DOI":"10.1097\/MCG.0000000000001023","article-title":"Clinical and Microbiological Effect of a Multispecies Probiotic Supplementation in Celiac Patients With Persistent IBS-type Symptoms: A Randomized, Double-Blind, Placebo-controlled, Multicenter Trial","volume":"53","author":"Francavilla R","year":"2019","journal-title":"J Clin Gastroenterol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1590\/s0004-2803.201700000-07","article-title":"Effects of probiotic intake on intestinal bifidobacteria of celiac patients","volume":"54","author":"Martinello F","year":"2017","journal-title":"Arq Gastroenterol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"9048574","DOI":"10.1155\/2016\/9048574","article-title":"Probiotics and the Microbiome in Celiac Disease: A Randomised Controlled Trial","volume":"2016","author":"Harnett J","year":"2016","journal-title":"Evid Based Complement Alternat Med"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1007\/s11136-023-03380-7","article-title":"Psychometric validation of the celiac disease-specific quality of life survey (CD-QOL) in adults with celiac disease in the United States","volume":"32","author":"Dochat C","year":"2023","journal-title":"Qual Life Res"}],"container-title":["Arquivos de Gastroenterologia"],"original-title":["Probi\u00f3ticos como terapia adjuvante para doen\u00e7a cel\u00edaca: al\u00edvio dos sintomas e melhora da qualidade de vida"],"link":[{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_pdf&pid=S0004-28032025000100205&tlng=en","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,21]],"date-time":"2025-07-21T15:04:56Z","timestamp":1753110296000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0004-28032025000100205&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":29,"alternative-id":["S0004-28032025000100205"],"URL":"https:\/\/doi.org\/10.1590\/s0004-2803.24612024-111","relation":{},"ISSN":["1678-4219","0004-2803"],"issn-type":[{"value":"1678-4219","type":"electronic"},{"value":"0004-2803","type":"print"}],"subject":[],"published":{"date-parts":[[2025]]},"article-number":"e24111"}}